Evo GLP

    Evo GLP: oversight for GLP-1 weight loss

    GLP-1 medicines make weight come off quickly. Evo GLP makes sure the right weight comes off. Targeted MRI body mapping and blood panels at 3 to 5 checkpoints a year show whether you are losing fat or muscle, and whether your liver, kidneys, pancreas and nutrition are keeping up. Waitlist open.

    Updated

    What is Evo GLP?

    Evo GLP is a longitudinal monitoring program for people on GLP-1 medication. At 3 to 5 checkpoints per year it measures visceral fat, muscle fat infiltration and liver health with MRI, and checks metabolic, kidney, pancreatic, hormonal and nutritional markers in blood, so that weight loss stays fat-dominant, muscle is preserved and treatment stays safe.

    Longitudinal monitoring platform for GLP-1 users, to ensure fat-dominant weight loss, muscle preservation, and metabolic safety and mitigate risks.

    Why monitor GLP-1 weight loss with MRI?

    A bathroom scale cannot tell fat from muscle. MRI can. Weight-loss trials have reported that a meaningful share of total weight lost on GLP-1 medicines can be lean mass, which matters for strength, metabolism and long-term health. Measuring muscle and visceral fat directly turns a number on a scale into information you can act on.

    Smart scales and bioimpedance estimate body composition from electrical resistance and are sensitive to hydration. DEXA is better, but it cannot separate fat inside muscle from muscle itself, nor assess the liver. MRI measures fat and muscle volume directly, repeatably and without radiation, which is why EVO uses it as the reference method. The same logic underpins Evo S for athletes.

    What does Evo GLP include?

    Body mapping (MRI screening)

    • VAT Volume: Quantification of Visceral Adipose Tissue (deep organ fat).
    • Myosteatosis Index: Measurement of fat infiltration within skeletal muscle.
    • Hepatobiliary Safety: Assessment of liver fat fraction and gallbladder morphology.

    Metabolic and cardiovascular panel

    • Glycemic Control: HbA1c, Fasting Glucose, and Insulin (HOMA-IR).
    • Lipid Proteomics: ApoB (preferred), Triglycerides, and LDL/HDL ratios.

    Organ and systemic safety

    • Renal Integrity: Creatinine, eGFR, and electrolyte balance (Na, K).
    • Pancreatic Surveillance: Serum Amylase and Lipase levels.
    • Hormonal Baseline: TSH (Thyroid) and Testosterone (anabolic reserve).

    Nutritional bioavailability

    • Micronutrient Status: Vitamin B12, Vitamin D, and Ferritin.
    • Protein Stability: Serum Albumin and Pre-albumin levels.

    How each measurement is used

    Evo GLP measurements and their relevance during GLP-1 treatment.
    What is measuredHowWhy it matters on GLP-1
    Visceral fat volumeMRI body mappingConfirms the fat you lose is the harmful deep fat around organs, not just subcutaneous fat.
    Muscle fat infiltration (myosteatosis)MRI body mappingTracks muscle quality; rising infiltration signals muscle is being lost or degraded.
    Liver fat and gallbladderMRI body mappingFatty liver often improves with weight loss, but rapid loss raises gallstone risk.
    HbA1c, fasting glucose, insulin (HOMA-IR)Blood panelShows whether metabolic control is improving as weight falls.
    ApoB, triglycerides, LDL/HDLBlood panelCardiovascular risk should fall with fat loss; ApoB is the preferred marker.
    Creatinine, eGFR, sodium, potassiumBlood panelKidney function and hydration can shift with reduced intake and nausea.
    Amylase and lipaseBlood panelPancreatic surveillance; pancreatitis is a recognised, if uncommon, risk.
    TSH and testosteroneBlood panelHormonal baseline and anabolic reserve, relevant to muscle preservation.
    B12, vitamin D, ferritin, albumin, pre-albuminBlood panelReduced appetite can mean reduced micronutrients and protein; these catch it early.

    How do Evo GLP checkpoints work?

    1. Baseline. Ideally before or soon after you start medication: MRI body mapping plus the full blood panel, collected at home.
    2. Checkpoints. Three to five per annual cycle, spaced to your rate of loss. Each repeats the key MRI measures and the relevant blood markers.
    3. Trend report. Every checkpoint is compared with your baseline: fat lost versus muscle lost, visceral fat change, liver fat, and any safety markers drifting out of range.
    4. Shared with your doctor. The report is written for you and for the clinician managing your prescription, so dose, protein intake and training can be adjusted with evidence.

    A longitudinal oversight layer: tests are calibrated to your progress through 3 to 5 strategic diagnostic checkpoints per annual cycle.

    Who should consider Evo GLP?

    People on GLP-1 medication (and their doctors) who want to confirm the weight they lose is fat, not muscle, and that liver, kidney and pancreas stay safe.

    • Anyone starting or already on semaglutide, tirzepatide or similar medication for weight management.
    • People over 40, for whom muscle loss during weight loss is harder to reverse.
    • People with a history of fatty liver, gallstones, kidney disease or pancreatitis, where safety monitoring matters most.
    • Doctors who want objective composition data for their GLP-1 patients.

    What Evo GLP does not do

    • It does not prescribe, supply or adjust medication.
    • It does not replace the monitoring your prescribing doctor requires.
    • It is not a whole-body cancer screen. For that, see Evo Core.
    • It cannot be performed with certain implants or in pregnancy; your concierge will screen for this.

    Pricing and availability

    Evo GLP is on a waitlist. Pricing is announced at launch and waitlist members hear first. Joining is free. See plans and pricing for how it compares with Evo Core and Evo S.

    Frequently asked questions about Evo GLP

    What is Evo GLP?

    Evo GLP is a longitudinal monitoring program for people taking GLP-1 medication such as semaglutide or tirzepatide. It uses targeted MRI body mapping and blood panels at 3 to 5 checkpoints a year to confirm that weight loss is fat-dominant, that muscle is preserved, and that liver, kidney, pancreas and nutritional markers stay within safe ranges.

    Why does muscle loss matter on GLP-1 drugs?

    Rapid weight loss from any cause includes some lean mass, and clinical trials of GLP-1 medicines have reported that a meaningful share of total weight lost can be lean tissue. Losing muscle lowers metabolic rate, strength and long-term resilience. Measuring muscle directly, rather than inferring it from a scale, is the only way to know what you are actually losing.

    How does MRI measure fat and muscle?

    MRI distinguishes fat from muscle and water with high precision. Evo GLP quantifies visceral adipose tissue (the deep fat around organs), measures fat infiltration inside skeletal muscle (myosteatosis), and assesses liver fat fraction and gallbladder morphology, all without radiation.

    Is Evo GLP only for people already on GLP-1 medication?

    It is designed around the GLP-1 journey, including a baseline before or soon after starting, but anyone undertaking rapid, medically supervised weight loss can benefit from the same monitoring. Your concierge will advise whether Evo GLP or Evo Core is the better fit.

    Does Evo GLP prescribe or supply GLP-1 medication?

    No. EVO does not prescribe, supply or adjust medication. Evo GLP provides objective measurements that you and your treating doctor use to make those decisions.

    How often are the checkpoints?

    Three to five checkpoints per annual cycle, calibrated to your rate of weight loss and your findings. A baseline is taken early, with follow-ups spaced to catch changes in muscle, visceral fat and organ markers while there is still time to act.

    When will Evo GLP be available and what will it cost?

    Evo GLP is on a waitlist. Pricing and launch dates will be announced to waitlist members first. Joining the waitlist is free and does not commit you to anything.

    Medical disclaimer

    Evo GLP is a monitoring program, not a treatment service. It does not diagnose conditions or make prescribing decisions, and it is not a substitute for care from the doctor managing your medication. Always discuss changes to dose, diet or exercise with your clinician.

    Related: GLP-1 muscle loss explained · FAQ · Conditions screened · EVO in Bengaluru